Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ana Merino-Trigo
Association of Patient Profile With Glycemic Control and Hypoglycemia With Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Pdb86 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Bulgaria
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb79 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Croatia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Achieve Control: A Pragmatic Clinical Trial of Insulin Glargine 300 U/mL Versus Other Basal Insulins in Insulin-Naïve Patients With Type 2 Diabetes
Postgraduate Medicine
Medicine
Glycaemic Control, Hypoglycaemia, and Weight Change With Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Japanese Adults With Type 2 Diabetes: A 12-Month Comparison by Concomitant Sulphonylurea and/or Glinide Use
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
In Silico Head-To-Head Comparison of Insulin Glargine 300 U/Ml and Insulin Degludec 100 U/Ml in Type 1 Diabetes
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People With Type 2 Diabetes
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Real-World Outcomes of Treatment With Insulin Glargine 300 u/mL Versus Standard-Of-Care in People With Uncontrolled Type 2 Diabetes Mellitus
Current Medical Research and Opinion
Medicine
New Insulin Glargine 300 Units{middle Dot}mL-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units{middle Dot}mL-1
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL−1 and Glargine 100 U mL−1 in Japanese People With Type 1 Diabetes Mellitus: A Crossover Pilot Study
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes